🏛️ Verified NIH Record • Updated 2025-01-23
The OPBC-07/microNAC Study (NCT06529302)
Association of Axillary Lymph Node Dissection With Oncological Outcomes in Patients With Residual Micrometastases After Neoadjuvant Chemotherapy: The OPBC-07/microNAC Study
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University Hospital, Basel, Switzerland
🩺 Plain-English Summary (8th-Grade Level)
The aim of this multicenter retrospective cohort study is to determine the safety of omission of axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy.
Who can join: Review the eligibility criteria below.
Location: Valleywise Health Medical Center — Phoenix, Arizona
Age range: 18 Years to 100 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (84 Sites)
Showing the first 25 of 84 sites.
- Valleywise Health Medical Center — Phoenix, Arizona
- Cedars-Sinai Medical Center — Los Angeles, California
- University of California — San Francisco, California
- Providence Saint John's Cancer Institute — Santa Monica, California
- University of Miami — Coral Gables, Florida
- Dana-Farber Cancer Institute — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Mayo Clinic — Rochester, Minnesota
- NYU Langone Health — New York, New York
- Memorial Sloan Kettering Cancer Center — New York, New York
- Montefiore Medical Center — New York, New York
- University of Rochester — Rochester, New York
- Duke University — Durham, North Carolina
- University of Pennsylvania — Philadelphia, Pennsylvania
- Fox Chase Cancer Center — Philadelphia, Pennsylvania
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- MD Anderson Cancer Center — Houston, Texas
- Swedish Cancer Institute — Seattle, Washington
- University of Washington — Seattle, Washington
- Sanatorio Modelo Quilmes — Quilmes,
- Chris O'Brien Lifehouse (COBL) — Sydney,
- Ordensklinikum Linz GmbH — Linz,
- Medical University of Vienna Chirurgie — Vienna,
- Hospital de Base do Distrito Federal — Brasília,
- Sirio Libanes Hospital Brasilia — Brasília,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
- A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California
Explore by condition: All Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.